Loading...
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer
PURPOSE: The noninterventional, prospective NIMES‐ROC phase IV study (NCT02825420) evaluated trabectedin plus pegylated liposomal doxorubicin (PLD) in real‐life clinical practice. PATIENTS AND METHODS: Eligible participants included adults with platinum‐sensitive recurrent ovarian cancer (PS‐ROC) wh...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018301/ https://ncbi.nlm.nih.gov/pubmed/33289956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13630 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|